Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

ZRANB1 leads to the deubiquitination of PIK3C3 on K29. 2 / 2

| 2

➶

reach

"TRABID antagonizes VPS34 K29 and K48 heterotypic ubiquitination even though it can not hydrolyze unanchored K48 diubiquitin chains 37."

33637724

➶

reach

"TRABID reduces VPS34 K29 and K48 ubiquitination to stabilize VPS34."

33637724

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...